Your browser doesn't support javascript.
loading
Anticancer drug discovery and pharmaceutical chemistry: a history
Braña, M. F; Sánchez-Migallón, A.
Affiliation
  • Braña, M. F; Instituto Canario de Investigación del Cáncer (ICIC). Spain
  • Sánchez-Migallón, A; Universidad de Castilla La Mancha. Spain
Clin. transl. oncol. (Print) ; 8(10): 717-728, oct. 2006. tab, ilus
Article in En | IBECS | ID: ibc-125319
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
There are several procedures for the chemical discovery and design of new drugs from the point of view of the pharmaceutical or medicinal chemistry. They range from classical methods to the very new ones, such as molecular modeling or high throughput screening. In this review, we will consider some historical approaches based on the screening of natural products, the chances for luck, the systematic screening of new chemical entities and serendipity. Another group comprises rational design, as in the case of metabolic pathways, conformation versus configuration and, finally, a brief description on available new targets to be carried out. In each approach, the structure of some examples of clinical interest will be shown (AU)
Subject(s)
Search on Google
Collection: 06-national / ES Database: IBECS Main subject: Biological Products / Chemistry, Organic / Chemistry, Pharmaceutical / Drug Evaluation, Preclinical / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin. transl. oncol. (Print) Year: 2006 Document type: Article
Search on Google
Collection: 06-national / ES Database: IBECS Main subject: Biological Products / Chemistry, Organic / Chemistry, Pharmaceutical / Drug Evaluation, Preclinical / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin. transl. oncol. (Print) Year: 2006 Document type: Article